Literature DB >> 7912592

Lens epithelium in senile cataract.

S H Tseng1, J S Yen, H L Chien.   

Abstract

This study aimed to clarify the role of lens epithelium in the mechanism of cataractogenesis. One hundred and twenty-six flat preparations of human lens epithelium obtained by endocapsular cataract extraction were studied. The mean lens epithelial cell density (LECD) was 3,683 +/- 655 cells/mm2; there was no significant difference with respect to age and sex (p > 0.05). A marked reduction in LECD, 2,857 cells/mm2, was noted in patients with advanced cataracts. The differences in LECD among the pure cortical, nuclear, and posterior subcapsular types of cataract were statistically insignificant (p > 0.05). We believe that a vicious cycle existed between the compromised lens epithelium and the formation of senile cataract: as a cataractous lens develops to a particular degree, the lens epithelium begins to lose its cell mass progressively and this results in the decreasing LECD. Simultaneously, the diminishing lens epithelial cell population leads to further cataract formation. Based on the outcome of this study, the authors stress the importance of the status of the lens epithelium in the formation of senile cataracts.

Entities:  

Mesh:

Year:  1994        PMID: 7912592

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  2 in total

1.  Changes in the lens epithelium with respect to cataractogenesis: light microscopic and Scheimpflug densitometric analysis of the cataractous and the clear lens of diabetics and non-diabetics.

Authors:  Sergey I Tkachov; Christine Lautenschläger; Dirk Ehrich; Hans Gert Struck
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-09-21       Impact factor: 3.117

2.  The OV-TL 12/30 clone of anti-cytokeratin 7 antibody as a new marker of corneal conjunctivalization in patients with limbal stem cell deficiency.

Authors:  Katerina Jirsova; Lubica Dudakova; Sarka Kalasova; Viera Vesela; Stanislava Merjava
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-29       Impact factor: 4.799

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.